Shedir Pharma Srl Unipersonale
MIL:SHE

Watchlist Manager
Shedir Pharma Srl Unipersonale Logo
Shedir Pharma Srl Unipersonale
MIL:SHE
Watchlist
Price: 4.86 EUR Market Closed
Market Cap: 55.5m EUR
Have any thoughts about
Shedir Pharma Srl Unipersonale?
Write Note

Shedir Pharma Srl Unipersonale
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Shedir Pharma Srl Unipersonale
Additional Paid In Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
Shedir Pharma Srl Unipersonale
MIL:SHE
Additional Paid In Capital
€8.6m
CAGR 3-Years
0%
CAGR 5-Years
18%
CAGR 10-Years
N/A
Newron Pharmaceuticals SpA
SIX:NWRN
Additional Paid In Capital
-€35.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Recordati Industria Chimica e Farmaceutica SpA
MIL:REC
Additional Paid In Capital
€83.7m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
0%
P
Pierrel SpA
MIL:PRL
Additional Paid In Capital
€16.1m
CAGR 3-Years
-13%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Friulchem SpA
MIL:FCM
Additional Paid In Capital
€4m
CAGR 3-Years
0%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Shedir Pharma Srl Unipersonale
Glance View

Market Cap
55.2m EUR
Industry
Pharmaceuticals

Shedir Pharma Group SpA operates as a holding company which engages in the research and development of nutraceuticals and medical devices. The company is headquartered in Mercato San Severino, Salerno and currently employs 71 full-time employees. The company went IPO on 2019-07-23. The firm markets its products in different forms and under the brand lines Shedir Farmaceutici, Deimos Farmaceutici, Phobos Farmaceutici, Menkar Farmaceutici and Greenplanet Divisione Farmaceutica. Its products cover a wide range of therapeutics areas, such as cardiovascular, dermatology, neurology, urology, gynecology and dental health, among others.

SHE Intrinsic Value
7.59 EUR
Undervaluation 36%
Intrinsic Value
Price

See Also

What is Shedir Pharma Srl Unipersonale's Additional Paid In Capital?
Additional Paid In Capital
8.6m EUR

Based on the financial report for Dec 31, 2023, Shedir Pharma Srl Unipersonale's Additional Paid In Capital amounts to 8.6m EUR.

What is Shedir Pharma Srl Unipersonale's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 5Y
18%

Over the last year, the Additional Paid In Capital growth was 0%.

Back to Top